These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10681229)

  • 1. Nephropathy in type 2 diabetes.
    Grace DM
    N Engl J Med; 2000 Feb; 342(6):441; author reply 442. PubMed ID: 10681229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastric banding and diabetes mellitus].
    Svacina S
    Vnitr Lek; 2004 May; 50(5):371-4. PubMed ID: 15305634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephropathy in type 2 diabetes.
    Vandor T
    N Engl J Med; 2000 Feb; 342(6):441; author reply 442. PubMed ID: 10681231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current guidelines for the prevention and treatment of diabetic nephropathy. International Diabetes Federation].
    Bilo HJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1847-9. PubMed ID: 7477510
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical monitoring of diabetic patients.
    Kokot F
    Clin Nephrol; 1996 Oct; 46(4):266-8. PubMed ID: 8905215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and bariatric surgery.
    Deitel M
    Obes Surg; 2000 Aug; 10(4):285. PubMed ID: 11109068
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical practice. Nephropathy in patients with type 2 diabetes.
    Remuzzi G; Schieppati A; Ruggenenti P
    N Engl J Med; 2002 Apr; 346(15):1145-51. PubMed ID: 11948275
    [No Abstract]   [Full Text] [Related]  

  • 8. Body mass index in type 2 diabetes mellitus complications: hypertensive diabetics and diabetic nephropathy.
    Idogun ES; Unuigbe EI; Famodu AA; Akinola OT
    Niger Postgrad Med J; 2006 Mar; 13(1):17-20. PubMed ID: 16633373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity in the service of Justice. New drug-combination leads to protection of the kidney].
    Streier K
    Fortschr Med; 1997 Nov; 115(32):54-5. PubMed ID: 9480271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of diabetic nephropathy].
    Hasslacher C
    Ther Umsch; 1988 Dec; 45(12):888-94. PubMed ID: 3065969
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 12. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases.
    Noya G; Cossu ML; Coppola M; Tonolo G; Angius MF; Fais E; Ruggiu M
    Obes Surg; 1998 Feb; 8(1):67-72. PubMed ID: 9562490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancing the study of prevention and treatment of diabetic nephropathy].
    Li N
    Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):327-8. PubMed ID: 11715468
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?
    Sferra L; Kelsberg G; Dodson S; Saseen J
    J Fam Pract; 2004 Jan; 53(1):68-9. PubMed ID: 14709273
    [No Abstract]   [Full Text] [Related]  

  • 15. Laparoscopic gastric banding in a kidney-pancreas transplant recipient with new onset type II diabetes mellitus associated with morbid obesity.
    Bonatti H; Schmitt T; Northup J; Schirmer B; Swenson BR; Pruett TL; Sawyer RG; Brayman K
    Clin Transplant; 2008; 22(6):829-32. PubMed ID: 18713268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of diabetes in the first year after gastric banding].
    Svacina S; Haas T; Fried M; Nedĕlníková K; Matoulek M
    Sb Lek; 2000; 101(1):83-7. PubMed ID: 10953636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of metabolic state and diabetes on the outcome at the end of first year after gastric banding.
    Nedelníková K; Svacina S; Haas T; Matoulek M; Fried M
    Obes Surg; 2000 Aug; 10(4):372-5. PubMed ID: 11007633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S; Richelsen B
    Ugeskr Laeger; 2006 Jan; 168(2):175-9. PubMed ID: 16403345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Il-receptor blockers and nephropathy in patients with type 2 diabetes.
    Farquhar D
    CMAJ; 2001 Nov; 165(10):1379. PubMed ID: 11760990
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of weight reduction on compensation in diabetic obese patients with non-insulin dependent diabetes mellitus].
    Szabó M
    Vnitr Lek; 1998 Mar; 44(3):145-50. PubMed ID: 9820092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.